↓ Skip to main content

Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

Overview of attention for article published in Journal of NeuroImmune Pharmacology, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
142 Mendeley
citeulike
1 CiteULike
Title
Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
Published in
Journal of NeuroImmune Pharmacology, April 2010
DOI 10.1007/s11481-010-9201-3
Pubmed ID
Authors

Alberto Ascherio, Kassandra L. Munger

Abstract

Epstein-Barr virus (EBV) infection results in a life-long persistence of the virus in the host's B-lymphocytes and has been associated with numerous cancers including Burkitt's lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma. There is considerable evidence that EBV infection is a strong risk factor for the development of multiple sclerosis. Early age at primary EBV infection is typically asymptomatic, but primary infection during adolescence or adulthood often manifests as infectious mononucleosis, which has been associated with a two- to threefold increased risk of MS. Most importantly, MS risk is extremely low in individuals who are EBV negative, but it increases several folds following EBV infection. Additional evidence supporting a role for EBV in MS pathogenesis includes the observations of elevated antibodies to EBV antigens (especially EBV nuclear antigen-1) prior to the onset of MS, and an increased risk of MS among EBV-positive children. The biological mechanism by which EBV may cause MS is not known, but several possibilities are discussed.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Spain 2 1%
United Kingdom 2 1%
Hungary 1 <1%
Portugal 1 <1%
Cyprus 1 <1%
Czechia 1 <1%
Unknown 131 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 21%
Student > Master 29 20%
Researcher 22 15%
Student > Bachelor 20 14%
Unspecified 15 11%
Other 26 18%
Readers by discipline Count As %
Medicine and Dentistry 51 36%
Agricultural and Biological Sciences 31 22%
Unspecified 18 13%
Biochemistry, Genetics and Molecular Biology 12 8%
Neuroscience 9 6%
Other 21 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2017.
All research outputs
#3,099,499
of 12,484,416 outputs
Outputs from Journal of NeuroImmune Pharmacology
#90
of 429 outputs
Outputs of similar age
#63,757
of 269,207 outputs
Outputs of similar age from Journal of NeuroImmune Pharmacology
#2
of 22 outputs
Altmetric has tracked 12,484,416 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 429 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,207 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.